Cabot Corporation $CBT Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. lessened its holdings in shares of Cabot Corporation (NYSE:CBT) by 7.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 270,737 shares of the specialty chemicals company’s stock after selling 22,224 shares during the period. JPMorgan Chase & Co. owned approximately 0.51% of Cabot worth $20,590,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in CBT. State of New Jersey Common Pension Fund D lifted its position in shares of Cabot by 5.7% in the third quarter. State of New Jersey Common Pension Fund D now owns 26,891 shares of the specialty chemicals company’s stock valued at $2,045,000 after acquiring an additional 1,456 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in Cabot by 62.7% during the third quarter. PNC Financial Services Group Inc. now owns 4,524 shares of the specialty chemicals company’s stock worth $344,000 after acquiring an additional 1,744 shares during the last quarter. Assetmark Inc. grew its stake in Cabot by 13.0% in the 3rd quarter. Assetmark Inc. now owns 7,123 shares of the specialty chemicals company’s stock worth $542,000 after acquiring an additional 821 shares during the period. MQS Management LLC acquired a new position in Cabot in the 3rd quarter valued at $369,000. Finally, Oppenheimer Asset Management Inc. lifted its stake in shares of Cabot by 3.8% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 45,601 shares of the specialty chemicals company’s stock worth $3,468,000 after purchasing an additional 1,670 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Price Performance

CBT opened at $76.24 on Tuesday. The company has a quick ratio of 1.09, a current ratio of 1.67 and a debt-to-equity ratio of 0.49. The company’s 50-day moving average price is $72.29 and its 200 day moving average price is $71.53. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $89.15. The firm has a market cap of $3.98 billion, a price-to-earnings ratio of 13.35, a price-to-earnings-growth ratio of 4.06 and a beta of 0.86.

Cabot (NYSE:CBT) last released its quarterly earnings data on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.13. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The business had revenue of $849.00 million for the quarter, compared to analysts’ expectations of $889.11 million. During the same quarter last year, the company earned $1.76 EPS. The company’s revenue for the quarter was down 11.1% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, sell-side analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be paid a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, February 27th. This represents a $1.80 dividend on an annualized basis and a yield of 2.4%. Cabot’s dividend payout ratio is currently 31.52%.

Wall Street Analysts Forecast Growth

CBT has been the topic of several research analyst reports. Jefferies Financial Group restated a “buy” rating and issued a $85.00 target price on shares of Cabot in a report on Wednesday, February 4th. Mizuho set a $75.00 price objective on shares of Cabot and gave the company a “neutral” rating in a research note on Wednesday, February 4th. JPMorgan Chase & Co. cut their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research report on Friday, November 28th. UBS Group boosted their price target on Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Finally, Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $73.75.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.